Incannex Healthcare Limited (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, is pleased to announce that it has completed analysis of data from the Phase 2 proof-of-concept clinical trial investigating IHL-42X for treatment of obstructive sleep […]
ARTICLES
First Female Pulmonary Chief at UM to Present Respiratory Health Lunch & Learn
Vitalograph is pleased to host a timely and important lunch and learn webinar on lung health with renowned lung expert and author, MeiLan Han, MD, Chief of Pulmonary and Critical Care at the University of Michigan and author of the book, Breathing Lessons available on Amazon. Dr. Han will be […]
Dale Introduces BreezeLock Endotracheal Tube Holder
Dale Medical Products, Inc. (Dale), the employee-owned company known for its high-quality, patient-friendly medical device securement solutions, is expanding its offering with its new BreezeLock® Endotracheal Tube Holder. Like the Dale® Stabilock Endotracheal Tube Holder, the new endotracheal tube holder features a soft, comfortable, flexible neckband with no hard plastic parts. The […]
Study Finds Association Between Inconsistent Sleep and Hypertension Risk
A study of more than two million nights of sleep and blood pressure data found that irregularities in sleep timing and duration were associated with an increased risk of hypertension. Results show that high sleep duration irregularity was associated with a 9% to 15% increase in hypertension risk. Furthermore, a 38-minute increase […]
Bedfont Scientific Receives FDA Clearance for NObreath FeNO Monitor
Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation. The NObreath®, which conforms to ATS and ERS guidelines1, is a portable, non-invasive device for the measurement of Fractional Exhaled Nitric Oxide (FeNO) […]
Nyxoah OSA Implantable One Step Closer to Full FDA Approval
Nyxoah SA announced that the U.S. Food and Drug Administration (FDA) has approved the use of Nyxoah’s next-generation Genio® 2.1 system for use in the Company’s DREAM U.S. IDE pivotal study. Genio® 2.1’s upgrades are entirely related to the external components of the Genio® system, as the implantable stimulator remains […]
ProSomnus to Present New OAT Data at SLEEP 2022
ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus will share data in three poster presentations at SLEEP 2022, the Annual Meeting of […]
Eisai to Present New Data On Lemborexant at SLEEP 2022
Eisai Co., Ltd. announced a total of seven poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (DAYVIGO® CIV) will be given at the 36th annual meeting of the Associated Professional Sleep Societies (SLEEP 2022), to be held from June 4 to June 8, 2022, in Charlotte, NC. […]
Jazz to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine
Jazz Pharmaceuticals plc announced that the Company and its partners will present 17 new abstracts from across its neuroscience portfolio at SLEEP 2022, the 36th annual meeting of the Associated Professional Sleep Societies (APSS) being held June 4-8, 2022. “Our latest research being presented at SLEEP 2022 provides important insights that benefit […]
🏆 2022 AASM High School Video Contest Winners
The American Academy of Sleep Medicine congratulates the three students selected as the winners of the 2022 AASM “Make Sleep Work for You” High School Video Contest, which focused on educating teens about the importance of healthy sleep. Watch the first place video. The annual contest is open to high school students […]













